Plazomicin Study in ESRD Patients Receiving IHD

Clinical trial NCT04699656 · COMPLETED

Trial details

NCT number: NCT04699656
Sponsor: Cipla USA Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2021-01-05
Primary completion: 2021-03-08
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.